FDA Adverse Event Injury Summary report: N

STRATTICE¿ RECONSTRUCTIVE TISSUE MATRIX

MDR report key: 6870353 · Received September 15, 2017

Report

Report Number
3002719998-2017-00025
Event Type
Injury
Date Received
September 15, 2017
Date of Event
July 19, 2016
Report Date
October 26, 2017
Manufacturer
TUTOGEN MEDICAL GMBH
Product Code
FTM
PMA / PMN Number
K142070
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE INFORMATION PROVIDED TO DATE INDICATED THAT THE XENOGRAFT REMAINS IMPLANTED AND NOT AVAILABLE FOR EVALUATION. THEREFORE, A COMPREHENSIVE RE-REVIEW WILL BE CONDUCTED OF THE MANUFACTURING RECORDS, STERILIZATION RUN REPORTS, ENVIRONMENTAL MONITORING RESULTS, QUALITY CONTROL / ASSURANCE REVIEWS AND RELEASE, AND THE COMPLAINT DATABASE FOR RELATED COMPLAINTS, ONCE THE UNIQUE IDENTIFIERS ARE PROVIDED TO RTI.

Additional Manufacturer Narrative · 1

THE REPORTED COMPLAINT IS NOT ASSOCIATED WITH A GRAFT MANUFACTURED BY RTI SURGICAL, INC.

Description of Event or Problem · 1

RTI SURGICAL, INC (RTI) RECEIVED A COMPLAINT NOTIFICATION ON 08/22/2017 INDICATING THAT A PATIENT UNDERWENT IMPLANTATION OF A FORTIVA PORCINE DERMIS ON AN UNKNOWN DATE, AS PART OF A HERNIA REPAIR CLINICAL STUDY. THE PATIENT DEVELOPED AN ENTEROCUTANEUS FISTULA ON (B)(6) 2016 AND A SEROMA ON (B)(6) 2016 (UNKNOWN SPECIFIC LOCATIONS). ADDITIONAL INFORMATION HAS BEEN REQUESTED. TO DATE, RTI HAS NOT RECEIVED ANY ADDITIONAL INFORMATION.

Description of Event or Problem · 1

RTI SURGICAL, INC RECEIVED ADDITIONAL INFORMATION ON 10/11/2017 INDICATING THAT THE ALLOGRAFT IMPLANTED IN THIS PATIENT WAS NOT A FORTIVA PORCINE DERMIS. THE GRAFT IMPLANTED WAS A STRATTICE RECONSTRUCTIVE TISSUE MATRIX . THE REPORTED COMPLICATIONS WERE ASSOCIATED WITH THE IMPLANTED STRATTICE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
649117 STRATTICE¿ RECONSTRUCTIVE TISSUE MATRIX PORCINE DERMIS FTM TUTOGEN MEDICAL GMBH NOT PROVIDED

Patients

Seq Age Sex Outcome Treatment
1 Other